1. Au JLS, Rustum Ym, Ledesma EJ, Mittelman A, Creaven PJ (1982) Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinoma. Cancer Res 42: 2930?2937
2. Ellims PH (1982) Thymidine as an anticancer agent, alone or in combination. A biochemical appraisal. Cancer Chemother Pharmacol 10: 1?6
3. Kirkwood JM, Ensminger W, Rosowski A, Papathanasopoulos N, Frei E (1980) Comparison of pharmacokinetics of 5-fluorouracil and 5-fluorouracil with concurrent thymidine infusions in a phase I trial. Cancer Res 40: 107?113
4. Martin DS, Stolfi RL, Spiegelman S (1978) Striking augmentation of the in vivo anticancer activity of 5-fluorouracil (FU) by combination with pyrimidine nucleosides: An RNA effect. Proc Am Assoc Cancer Res 19: 221
5. Martin DS, Stolfi RL, Sawyer RC, Nayak R, Spiegelman S, Young CW, Woodcock T (1980) An overview of thymidine. Cancer 45: 1117?1128